Fujifilm Medical Systems U.S.A. announced Monday, July 1, that its ASPIRE Cristalle with Digital Breast Tomosynthesis (DBT) mammography unit will now exclusively be sold in the Midwest through RadSource Imaging Technologies.
The arrangement includes all sales, service and support for Fujifilm’s breast imaging solutions in Missouri, Oklahoma, Kansas, Iowa and Nebraska.
“We are pleased to expand our strategic alliance between Fujifilm and RadSource Imaging Technologies,” Rick Banner, senior director of marketing for Fujifilm Medical Systems U.S.A., said in a prepared statement. “The newly strengthened cooperation will create an opportunity to expand sales outreach and help provide more healthcare providers and patients with the necessary tools needed to diagnosis and provide better patient care.”
“The Fujifilm digital mammography solution is designed with every aspect of a patient's experience in mind, making it possible to increase patient comfort and improve the patient experience,” Michael N. Wray, president and CEO of RadSource Imaging Technologies, said in the same statement. “At RadSource, we are excited to collaborate with Fujifilm and supporting their team in providing clinicians with an easy-to-use, reliable system that is also designed to improve image quality, streamline workflow and enhance patient outcomes.”
Michael has more than 16 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.